Does p-glycoprotein play a role in gastrointestinal absorption and cellular transport of dietary cholesterol?

Drug Development and Industrial Pharmacy

Volumn 32, Issue 6, 2006, Pages 779-782

  Leon, C ^a   Sachs Barrable, K ^a   Wasan, K M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cellular transport; Cholesterol; Gastrointestinal absorption; mdr1; P glycoprotein

Indexed keywords

ABC TRANSPORTER; AMIODARONE; CHOLESTEROL; COLCHICINE; CYCLOSPORIN A; DAUNORUBICIN; DIGOXIN; FORSKOLIN; GLYCOPROTEIN P; LIPOPROTEIN; METHOTREXATE; PROGESTERONE; PROTEIN INHIBITOR; TAMOXIFEN; TRIFLUOPERAZINE; VERAPAMIL; VINBLASTINE;

CELL LINE; CELL MEMBRANE; CELL TRANSPORT; CHOLESTEROL TRANSPORT; DIETARY INTAKE; GASTROINTESTINAL ABSORPTION; HELA CELL; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BIOLOGICAL TRANSPORT; CHOLESTEROL, DIETARY; GASTROINTESTINAL TRACT; HUMANS; INTESTINAL ABSORPTION; P-GLYCOPROTEIN;

EID: 33745602106     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600559073     Document Type: Review

References (20)

1. Bourgault, C. et al. (2005). Statin therapy in Canadian patients with hypercholesterolemia: The Canadian Lipid Study - Observational (CALIPSO). Can. J. Cardiol. 21 1187-1193.
2. Breier, A., Barancik, M., Sulova, Z., & Uhrik, B. (2005). P-glycoprotein - implications of metabolism of neoplastic cells and cancer therapy. Curr. Cancer Drug Targets. 5, 457-468.
3. Chang, G. (2003). Multidrug resistance ABC transporters, FEBS Lett. 555, 102-105.
4. Chow, C., Donovan, L., Manuel, D., Johansen, H., & Tu, J. V. (2005). Regional variation in self-reported heart disease prevalence in Canada. Can. J. Cardiol. 21 1265-1271.
5. Drescher, S. et al. (2003). P-glycoprotein-mediated intestinal and biliary digoxin transport in humans. Clin. Pharmacol. Ther. 73, 223-231.
6. Field, F. J., Born, E., Murthy, S., & Mathur, S. N. (1998). Transport of cholesterol from the endoplasmic reticulum to the plasma membrane is constitutive in CaCo-2 cells and differs from the transport of plasma membrane cholesterol to the endoplasmic reticulum. J. Lipid Res. 39, 333-343.
7. Glavinas, H., Krajcsi, P., Cserepes, J., & Sarkadi, B. (2004). The role of ABC transporters in drug resistance, metabolism and toxicity. Curr. Drug Deliv. 1, 27-42.
8. Hoffmeyer, S. et al. (2000). Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. U. S. A 97, 3473-3478.
9. Hu, C. C., Qing, K., & Chen, Y. (2004). Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice. Obes. Res. 12, 1264-1270.
10. Hui, D. Y., & Howles, P. N. (2005). Molecular mechanisms of cholesterol absorption and transport in the intestine. Semin. Cell Dev. Biol. 16, 183-192.
11. Kunta, J. R., & Sinko, P. J. (2004). Intestinal drug transporters: in vivo function and clinical importance, Curr. Drug Metab 5, 109-124.
12. Lam, P., Wang, R., & Ling, V. (2005). Bile Acid Transport in Sister of P-Glycoprotein (ABCB11) Knockout Mice. Biochemistry 44, 12598-12605.
13. Le Goff, G. W., Settle M., Greene, D. J., Morton, R. E., & Smith, J. D. (2005). Reevaluation of the role of the multidrug resistant P-glycoprotein in cellular cholesterol homeostasis, J. Lipid Res. Oct 7th, Epub.
14. Luker, G. D., Dahlheimer, J. L., Ostlund, R. E., Jr., & Piwnica-Worms, D. (2001). Decreased hepatic accumulation and enhanced esterification of cholesterol in mice deficient in mdr1a and mdr1b Pglycoproteins. J. Lipid Res. 42, 1389-1394.
15. Plosch, T. et al. (2002). Mdr P-glycoproteins are not essential for biliary excretion of the hydrophobic heme precursor protoporphyrin in a griseofulvin-induced mouse model of erythropoietic protoporphyria. Hepatology 35, 299-306.
16. Rodrigues, A. C. et al. (2005). High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descent, Braz. J. Med. Biol. Res. 38, 1389-1397.
17. Tessner, T. G., & Stenson, W. F. (2000). Overexpression of MDR1 in an intestinal cell line results in increased cholesterol uptake from micelles. Biochem. Biophys. Res. Commun. 267, 565-571.
18. Tous, M. et al. (2005). Turpentine-induced inflammation reduces the hepatic expression of the multiple drug resistance gene, the plasma cholesterol concentration and the development of atherosclerosis in apolipoprotein E deficient mice. Biochim. Biophys. Acta 1733, 192-198.
19. Turley, S. D. (2004). Cholesterol metabolism and therapeutic targets: rationale for targeting multiple metabolic pathways. Clin. Cardiol. 27 III16-21.
20. Wang, E., Casciano, C. N., Clement, R. P., & Johnson, W. W. (2000). Cholesterol interaction with the daunorubicin binding site of P-glycoprotein. Biochem. Biophys. Res. Commun. 276, 909-916.